- Home
- BUDA vs ANVS Comparison
BUDA vs ANVS Comparison
Compare BUDA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BUDA | ANVS |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 111.3M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | BUDA | ANVS |
|---|---|---|
| Price | $10.25 | $2.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 17.0K | ★ 358.2K |
| Earning Date | 03-26-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.61 | $1.11 |
| 52 Week High | $10.69 | $5.50 |
Technical Indicators
Market Signals| Indicator | BUDA | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 47.40 |
| Support Level | $8.06 | $2.29 |
| Resistance Level | $10.55 | $2.63 |
| Average True Range (ATR) | 0.90 | 0.22 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 55.02 | 36.05 |
Price Performance
Historical ComparisonAbout BUDA Buda Juice Inc. Common Stock
Buda Juice Inc operates in a competitive beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never pasteurized, never HPP- processed, never UV- treated and always cold.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.